| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/28/2005 | US20050165063 Amine compounds and use thereof |
| 07/28/2005 | US20050165055 Novel substituted indoles |
| 07/28/2005 | US20050165033 mediated by prostaglandin D2, a ligand for orphan receptor CRTH2; rhinitis; N-substituted by a benzothiazolyl, a pyrimidinyl, an imidazolyl, an oxazolyl, or a thiazolyl |
| 07/28/2005 | US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165007 Benzimidazoles and analogs thereof as antivirals |
| 07/28/2005 | US20050165005 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 07/28/2005 | US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 07/28/2005 | US20050164954 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition |
| 07/28/2005 | US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides |
| 07/28/2005 | US20050164868 Non-heating clay composites for building materials |
| 07/28/2005 | US20050164120 High photosensitivity, visible laser recording materials; comprised of novel squarylium compound metal complexes, free radical generators and monomers |
| 07/28/2005 | DE4243381B4 3(2H)-Pyridazinonderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie diese enthaltende Arzneimittel und ihre Verwendung 3 (2H) -pyridazinone derivatives, processes and intermediates for their preparation and pharmaceutical compositions containing them and their use |
| 07/28/2005 | DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 07/28/2005 | CA2553200A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 07/28/2005 | CA2552953A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 07/28/2005 | CA2552740A1 Indolylmaleimde derivatives as pkc inhibitors |
| 07/28/2005 | CA2552738A1 Indolylmaleimide derivatives |
| 07/28/2005 | CA2552663A1 Crystalline forms of rizatriptan benzoate |
| 07/28/2005 | CA2552403A1 Benzimidazole derivatives |
| 07/28/2005 | CA2551948A1 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors |
| 07/28/2005 | CA2551770A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis |
| 07/28/2005 | CA2551639A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/28/2005 | CA2551495A1 Conjugated small molecules |
| 07/28/2005 | CA2548982A1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride |
| 07/28/2005 | CA2547080A1 Heterocyclic protein kinase inhibitors and uses thereof |
| 07/27/2005 | EP1557415A1 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1557410A2 Bacterial gyrase inhibitors and uses thereof |
| 07/27/2005 | EP1557409A1 5HT2C receptor modulators |
| 07/27/2005 | EP1556381A1 Pyrazole amides for treating hiv infections |
| 07/27/2005 | EP1556373A1 Cannabinoid receptor ligands and uses thereof |
| 07/27/2005 | EP1556362A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/27/2005 | EP1556361A2 2-alkyl-(2-amino-3-aryl-propionyl)-piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 07/27/2005 | EP1556346A1 1-phenylpyrrolidine-2-one-3-carboxamides |
| 07/27/2005 | EP1556052A2 Mitotic kinesin inhibitors |
| 07/27/2005 | EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 07/27/2005 | EP1556032A1 Agent for preventing or treating neuropathy |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | EP1133490B1 Piperazinone derivatives |
| 07/27/2005 | CN1646523A Substituted 4-pyrazolyl pyrazolines used for pest control |
| 07/27/2005 | CN1646522A Processes for producing indole compound |
| 07/27/2005 | CN1646521A Substituted 4-hetaryl-pyrazolines as pest control agents |
| 07/27/2005 | CN1646502A Triazole derivatives as tachykinin receptor antagonists |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646495A Amine compounds and use thereof |
| 07/27/2005 | CN1646493A 5HT2C receptor modulators |
| 07/27/2005 | CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles |
| 07/27/2005 | CN1646446A Non-heating clay composites for building materials |
| 07/27/2005 | CN1644582A Pyrazole contained diheterocyclic compound, its preparation and use |
| 07/26/2005 | US6921821 Antagonists of melanin concentrating hormone receptor |
| 07/26/2005 | US6921760 Psychotherapeutic agents. |
| 07/21/2005 | WO2005066175A2 Carbapenem intermediates and processes for their preparation |
| 07/21/2005 | WO2005066173A2 Processes for the preparation of substituted azetidinone |
| 07/21/2005 | WO2005066165A1 N-substituted piperidine and piperazine derivatives |
| 07/21/2005 | WO2005066159A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005066158A2 An improved process for the synthesis of losartan potassium |
| 07/21/2005 | WO2005066157A1 3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators |
| 07/21/2005 | WO2005066156A1 Selective kinase inhibitors |
| 07/21/2005 | WO2005066137A1 2,5-diaryl-1h-imidazole-4-carboxamides as neurokinin-3 receptor modulators for the treatment of central nervous system and peripheral diseases |
| 07/21/2005 | WO2005066126A1 Cb1 modulator compounds |
| 07/21/2005 | WO2005065779A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | WO2005065688A1 New derivatives of 6-4{4-[1h-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one |
| 07/21/2005 | WO2005065680A1 Cyclic guanidines, compositions containing such compounds and methods of use |
| 07/21/2005 | WO2005065183A2 Mitotic kinesin inhibitors |
| 07/21/2005 | WO2005065154A2 Novel esters of aryl benzimidazole sulfonic acids and sunscreen compositions containing same |
| 07/21/2005 | WO2005042497A3 Benzimidazoles useful as modulators of ion channels |
| 07/21/2005 | WO2005028452A9 Substituted triazole derivatives as oxytocin antagonists |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/21/2005 | WO2004054986A8 Process for the preparation of pyrimidine compounds |
| 07/21/2005 | US20050159605 For treatment of Parkinson's disease or cardiovascular disorders |
| 07/21/2005 | US20050159603 For arachnids and nematodes |
| 07/21/2005 | US20050159585 Forming acyl azide function on acid group of amino acid derivative, then transforming to isocyanate |
| 07/21/2005 | US20050159584 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers |
| 07/21/2005 | US20050159475 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 07/21/2005 | US20050159473 3-Substituted oxindole beta3 agonists |
| 07/21/2005 | US20050159469 HIV protease inhibiting compounds |
| 07/21/2005 | US20050159468 Drugs for antiproliferation agent for pyrrolidine compounds |
| 07/21/2005 | US20050159467 5-Aryltetrazole compounds and uses thereof |
| 07/21/2005 | US20050159462 Elevates extracellular adenosine concentration for antiinflammatory and immunosuppressive effects; reaction of imidazole-4-carboxamide with a hydroxyalkylbenzoxazole or benzothiazole compound; 1-[4-hydroxy-1-(2-phenyl-4-benzoxazolyl)-3-pentyl]-imidazole-4-carboxamide |
| 07/21/2005 | US20050159452 Nociceptin analogs |
| 07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 07/21/2005 | US20050159437 Pharmaceutical agents |
| 07/21/2005 | US20050159435 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 07/21/2005 | US20050159431 Substituted alkyl uracils and thereof |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | US20050159424 pharmaceutically-acceptable salts, prodrugs, solvates, isomers, and/or hydrates thereof, wherein Q is an optionally-substituted phenyl, pyridyl, pyridazinyl, pyrimidinyl, or pyrazinyl ring; R2 is alkyl or an amino group as defined herein; and Z is optionally-substituted oxadiazolyl or C( .dbd. O)NR6, |
| 07/21/2005 | US20050159421 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 07/21/2005 | US20050159418 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/21/2005 | DE10359026A1 Verfahren zur Herstellung von Tetrahydrogeranylaceton A process for preparing tetrahydrogeranylacetone |
| 07/21/2005 | CA2552726A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | CA2551346A1 N-substituted piperidine and piperazine derivatives |
| 07/21/2005 | CA2549641A1 Mitotic kinesin inhibitors |
| 07/21/2005 | CA2549396A1 Cb1 modulator compounds |
| 07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | CA2547785A1 Cyclic guanidines, compositions containing such compounds and methods of use |
| 07/20/2005 | EP1555260A1 Phenyltetrazole compounds |